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A reassortant H9N2 influenza virus 
containing 2009 pandemic H1N1 
internal-protein genes acquired 
enhanced pig-to-pig transmission 
after serial passages in swine
José Carlos Mancera Gracia1, Silvie Van den Hoecke2,3, Juergen A. Richt4, Wenjun Ma4, Xavier 
Saelens  2,3 & Kristien Van Reeth1
Avian H9N2 and 2009 pandemic H1N1 (pH1N1) influenza viruses can infect pigs and humans, raising 
the concern that H9N2:pH1N1 reassortant viruses could emerge. Such reassortants demonstrated 
increased replication and transmissibility in pig, but were still inefficient when compared to pH1N1. 
Here, we evaluated if a reassortant virus containing the hemagglutinin and neuraminidase of A/quail/
Hong Kong/G1/1997 (H9N2) in the A/California/04/2009 (pH1N1) backbone could become better 
adapted to pigs by serial passaging. The tropism of the original H9N2:pH1N1 (P0) virus was restricted to 
the nasal mucosa, with no virus detected in the trachea or lungs. Nevertheless, after seven passages the 
H9N2:pH1N1 (P7) virus replicated in the entire respiratory tract. We also compared the transmissibility 
of H9N2:pH1N1 (P0), H9N2:pH1N1 (P7) and pH1N1. While only 2/6 direct-contact pigs showed nasal 
virus excretion of H9N2:pH1N1 (P0) ≥five days, 4/6 direct-contact animals shed the H9N2:pH1N1 
(P7). Interestingly, those four animals shed virus with titers similar to those of the pH1N1, which 
readily transmitted to all six contact animals. The broader tissue tropism and the increased post-
transmission replication after seven passages were associated with the HA-D225G substitution. Our 
data demonstrate that the pH1N1 internal-protein genes together with the serial passages favour H9N2 
virus adaptation to pigs.
H9N2 avian influenza viruses are currently endemic in poultry in South East Asia and the Middle East1. Since the 
late 1990s, H9N2 viruses have been occasionally isolated from humans and swine in China, leading to increasing 
concerns about their pandemic potential2–8. However, all reported human or swine H9N2 virus infections were 
dead-end events and the virus failed to spread within the human or swine population9.
A significant proportion of poultry H9N2 field isolates contains a leucine instead of glutamine residue at posi-
tion 226 in the hemagglutinin (HA) receptor-binding site (RBS) (HA-Q226L, H3 numbering used throughout). 
This mutation has been shown to enhance HA binding to terminal α2,6-linked sialic acids (Siaα2,6Gal) and to 
improve the replication of H9N2 viruses in human airway epithelial cells in vitro, supporting concerns about their 
pandemic potential10–12. The binding of the viral HA to sialyloligosaccharides, present on the host cell surface, is 
the first step for influenza virus infection. Because of the predominant expression of Siaα2,6Gal in human and 
swine upper respiratory tract13, 14, most human and swine influenza viruses more willingly bind to receptors that 
contain Siaα2,6Gal15. In contrast, avian influenza viruses preferentially bind sialic acids linked to galactose by an 
α2,3 linkage (Siaα2,3Gal). Therefore, a switch from Siaα2,3Gal to Siaα2,6Gal receptor-binding preference is con-
sidered an important step for avian influenza virus adaptation to mammals16. Nevertheless, enhanced Siaα2,6Gal 
binding is not entirely sufficient to make H9N2 viruses transmissible between mammals12, 17, 18. This suggests that 
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other amino acid substitutions and/or an adequate constellation of internal genes is also required for efficient 
transmission of H9N2 viruses between mammals.
Due to the segmented nature of the influenza viruses, the RNA segments of two (or more) different influenza 
viruses can “reassort” when co-infecting the same host cell, thereby generating progeny viruses with proper-
ties different from the parental viruses19. In that sense, the sporadic isolation of avian H9N2 influenza viruses 
from pigs and humans in China increases the possibility of co-infections with endemic swine or human influ-
enza viruses, which could result in the generation of novel reassortant viruses with enhanced transmissibility in 
mammals.
The 2009 pandemic H1N1 virus (pH1N1) is a swine-origin reassortant virus containing human, swine 
and avian influenza virus genes20. After its first appearance in 2009, the virus has spread around the world in 
both human and swine populations21. Moreover, novel reassortant viruses containing pH1N1 internal-protein 
and surface-protein genes from other endemic swine influenza virus have been isolated frequently from pigs 
worldwide22–25. In addition, H3N2 swine influenza viruses containing the pH1N1-derived matrix (M) protein 
gene (H3N2 variant) were isolated from 364 human cases in the US since 201126. This suggests that pH1N1 
internal-protein genes are compatible with several surface-protein gene combinations and allow for robust rep-
lication in mammals.
In ferret transmission studies, a reassortant H9N2 virus containing pH1N1 internal-protein genes read-
ily transmitted to all contact animals by respiratory droplets27. In pigs similar reassortant viruses also showed 
increased transmission when compared to the parental H9N2. However, their transmission was still not as effi-
cient as that of swine-adapted viruses like pH1N117, 28. We previously demonstrated that serial passages of A/quail/
Hong Kong/G1/1997 (H9N2) virus in pigs slightly enhanced replication and transmission in swine (Mancera 
Gracia et al.29). Although the resulting pig-adapted virus carried a number of mutations compared to the paren-
tal virus, transmission was still less efficient than that of naturally circulating viruses. In the present study, we 
have examined the replication and transmissibility after ten serial pig passages of a reassortant virus contain-
ing A/quail/Hong Kong/G1/1997 (H9N2) surface-protein genes and NP gene within the A/California/04/2009 
(pH1N1) background to evaluate if the pH1N1 backbone confers an advantage in H9N2 adaptation to pigs. This 
serial passaging of the H9N2:pH1N1 reassortant resulted in a virus that replicated in and transmitted between 
pigs at high rates. The predominant mutation in the passaged reassortant virus was an aspartic acid to glycine at 
position 225 in the HA RBS. Therefore, our results showed that the combination of reassortment and mutations 
induced by the serial passages generated a virus with a predominant mutation at position 225 in HA RBS that 
replicated and transmitted at high rates in pigs.
Results
Serial passages of a reassortant H9N2 virus resulted in increased virus replication. To evaluate 
if serial pig infections made reassortant H9N2 viruses better adapted to swine, ten blind serial passages were per-
formed in influenza naïve pigs. For each passage two co-housed animals were intranasally inoculated with 106,5 
TCID50 of H9N2:pH1N1 (P0). To determine nasal virus excretion, individual pigs were swabbed daily from 0 to 
four days post-inoculation (dpi). None of the pigs showed clinical signs of disease. The reassortant H9N2 virus 
was detected in nasal swabs of all experimentally infected pigs. The highest amount of virus was excreted during 
passages three and eight (Fig. 1). At four days after infection, pigs were euthanized and samples from the entire 
respiratory tract were collected to determine the viral load. Infectious virus was recovered from the respiratory 
tract of all pigs during all ten serial passages (Table 1). Replication rates were higher in the upper respiratory tract 
(nasal mucosa: respiratory and olfactory parts) with all 40 out of 40 (100%) samples testing positive, when com-
pared to the lower respiratory tract (trachea and lungs) with 81 out of 140 (58%) samples testing positive. In the 
first passage, no virus could be isolated from the lower respiratory tract. In contrast, during passages two, three 
and eight, the virus was detected in 17 out of 18 (93%) samples, indicating replication in the entire respiratory 
tract (Table 1).
After seven serial passages in pigs, the reassortant H9N2:pH1N1 virus showed enhanced con-
tact transmission. To compare the level of adaptation of the reassortant virus before and after serial passages 
in pigs, we performed direct-contact transmission experiments with the H9N2:pH1N1 (P0) virus and its descend-
ent isolated after seven passages in pigs (H9N2:pH1N1 (P7)). The latter virus was chosen because virus titers in 
nasal swabs and the respiratory tract samples were highest at this passage, suggesting a substantial degree of 
swine-adaptation. As a positive control, we used a representative swine-adapted virus, the A/California/04/2009 
(pH1N1) virus (A/Cal/04/09)23. All three viruses were amplified in MDCK cells before pig inoculation, and the 
transmission experiment was performed in triplicate for each virus. Figure 2 illustrates the nasal virus shedding 
of the inoculated and the co-housed direct-contact animals. All animals remained clinically healthy, based on 
clinical observation. All inoculated pigs excreted virus between days one and seven post-inoculation. A compar-
ison of the averages of the areas under the curve (AUC) revealed a lower virus excretion for H9N2:pH1N1 (P0) 
(mean AUC 19.4) and H9N2:pH1N1 (P7) (24.0) than for A/Cal/04/09 (26.6), even though these differences were 
not statistically significant (p >0.05). All three viruses reached a maximum virus titer ≥6.5 log10 TCID50/100 mg 
of secrete. All inoculated animals developed neutralizing antibodies against the homologous virus and these were 
highest for the A/Cal/04/09 infected pigs (Table 2).
As expected, all six A/Cal/04/09 direct-contact pigs excreted high amounts of virus (AUC >17) and serocon-
verted with VN titers ≥192. While all six direct-contact animals in the H9N2:pH1N1 (P0) group also serocon-
verted and excreted virus, only two shed virus with an AUC >6. In the H9N2:pH1N1 (P7) group, in contrast, 
just four out of six direct-contact animals excreted virus but all of them showed an AUC >21, similar to the A/
Cal/04/09 group. The remaining two H9N2:pH1N1 (P7) direct-contact pigs did not excrete any virus and failed 
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 1323  | DOI:10.1038/s41598-017-01512-x
Figure 1. Nasal virus shedding of the reassortant H9N2 virus containing pH1N1 internal-protein genes 
(H9N2:pH1N1) during ten blind serial pig passages. Two pigs (solid line and dashed line) were used for in each 
passage, each line represents the virus titers in nasal swabs of an individual pig. The detection limit of the test is 
indicated with a dotted line at 1.7 log10TCID50/100 mg of secretion.
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to seroconvert. VN titers in the six H9N2:pH1N1 (P0) and four out of six H9N2:pH1N1 (P7) direct-contact pigs 
were <256.
Mutations associated with enhanced transmission. We next compared the variants present in the 
H9N2:pH1N1 (P0) virus population and the H9N2:pH1N1 (P7) virus isolated from the nasal mucosa of a directly 
inoculated pig and the direct-contact pig with the highest nasal excretion in the transmission study. By com-
paring the virus population from the directly-inoculated and the direct-contact pigs we aimed to determine 
if the mutations selected during the serial passaging were maintained after transmission or if the transmission 
itself favored the acquirement of a different set of mutations. In addition, the H9N2:pH1N1 (P0) virus stock was 
included to determine whether the detected variants in the passage seven virus were already present in the virus 
stock before pig adaptation. Illumina MiSeq deep sequencing was performed on full genome RT-PCR products 
of the samples. Sequencing of H9N2:pH1N1 (P0) virus revealed contamination of the H9N2:pH1N1 virus stock 
with H9N2 internal-protein genes, which were most pronounced for the PB1, NS and NP gene segments (see 
Table 3). Interestingly, passage of the reassortant H9N2:pH1N1 virus stock in pigs resulted in the selection of 
a virus that had lost these internal-protein-coding H9N2 gene segments, except for the NP segment which was 
still of H9N2-origin after seven pig passages. Sequence analysis of the H9N2:pH1N1 (P7) virus after contact 
transmission showed that the genetic makeup of this virus was nearly identical to the H9N2:pH1N1 (P7) stock 
virus. The selection for a H9N2 virus with the pH1N1-origin internal protein-coding gene segments suggests a 
strong genetic bottleneck that leads to elimination of reassortant viruses with H9N2 internal protein-coding gene 
segments upon viral passaging in pigs. The nonsynonymous variants that were detected at a frequency ≥5% in 
the H9N2:pH1N1 (P7) stock virus and the H9N2:pH1N1 (P7) virus isolated from the direct-contact pig after 
mapping the sequencing reads to the de novo assembled consensus sequence of the H9N2:pH1N1 (P7) stock 
virus are shown in Table 4. As a consequence of the contamination, the sequencing reads of the H9N2:pH1N1 
(P0) stock virus were mapped to a reference genome composed of the de novo assembled consensus sequence 
of the H9N2:pH1N1 (P7) stock virus and the reference sequence for the A/quail/Hong Kong/G1/1997(H9N2) 
virus. The nonsynonymous variants detected at a frequency ≥0.5% in the H9N2:pH1N1 (P7) genome are shown 
in Supplementary Table S1.
The H9N2:pH1N1 (P7) stock virus showed variation above 5% at positions 535 and 615 of the basic poly-
merase 2 protein (PB2), position 119 of the HA and position 179 of the non-structural 1 protein (NS1) (Table 4). 
Nonetheless, those variants were not maintained after transmission to the contact pig. Interestingly, only one 
mutation associated with an amino acid substitution was selected after seven passages and maintained after 
transmission, i.e. the substitution of aspartic acid by glycine at position 225 of the HA RBS (HA-D225G). This 
mutation was absent (Supplementary Table S1) in the H9N2:pH1N1 (P0) virus stock and present in 47.4% and 
99.7% of the sequences derived from the viral population isolated after seven passages and the transmitted virus, 
Number 
of passage
Pig 
number
Virus titer (log10 TCID50/gram of tissue) at day 4 post-inoculationa
Nasal mucosa 
respiratory 
part
Nasal 
mucosa 
olfactory 
part
Proximal 
trachea
Distal 
trachea
Apical + cardiac 
lobe right
Apical + cardiac 
lobe left
Diaphragmatic 
lobe right
Diaphragmatic 
lobe left
Accessory 
lobe
1
#1 5.3 5.5 <b < < < < < <
#2 4.5 5 < < < < < < <
2
#3 5.7 5.7 2 4.2 < 3.3 2 3.5 2.3
#4 7 5.7 4.3 4 4.3 2.5 2.5 3.8 2.5
3
#5 5.7 5.5 5.7 4.7 2.3 3.7 2.3 3 1.7
#6 5.7 7.3 2.7 2 2.3 4.5 1.7 2.5 <
4
#7 5.5 6.3 2.3 3.8 1.7 < 3.7 < 1.7
#8 6.3 5.5 5 4.7 5.7 4 4.5 4.5 2.7
5
#9 6 1.7 1.7 < < < < < <
#10 4.7 2.5 4.2 2.7 6 2,8 3.2 < 5.5
6
#11 5.5 3.5 1.7 < < < < < <
#12 6.3 4 < < < < < < <
7
#13 5.7 5.5 3.3 2.5 < 1.7 2.8 < <
#14 5.5 4.3 1.7 < < < < < <
8
#15 6.3 7 4.3 5.5 5.3 5.5 5.5 5.5 4.5
#16 6.7 6.3 2.5 2.8 < 3.2 4,8 3,3 4,3
9
#17 6.5 6.7 1.7 < < < 1.7 < <
#18 6 5.5 2.5 3.5 < 5.5 4.3 3.5 2,7
10
#19 7 5.3 1.7 < 2 < 3.5 2.5 <
#20 6.8 3.7 1.7 5 5.5 2.2 < 4.7 <
Table 1. Distribution of reassortant H9N2 virus containing pH1N1 internal-protein genes in the respiratory 
tract during ten serial passages in pigs. aVirus titers are shown for each individual pig (#). b<detection limit 
(1,7 log 10 TCID50/gram of tissue).
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respectively. Two other mutations appeared de novo after transmission at a frequency >15%: a substitution of 
alanine to valine at position 115 of the NS1 and a substitution of threonine to alanine at position 58 of the PB2.
Discussion
Since the late 1990s, avian H9N2 viruses have been isolated from pigs and humans, so far always as dead end 
events3, 8, 30. However, the continuous exposure of humans and pigs to avian H9N2 viruses might pose a real threat 
for public health if these viruses would acquire the genetic changes that allow them to transmit efficiently between 
mammals. In this study, we evaluated the efficiency of direct-contact transmission between pigs of a reassor-
tant H9N2 virus containing pH1N1 internal-protein genes, and the effect of serial pig passages on transmission 
Figure 2. Nasal virus shedding and direct-contact transmission of H9N2:pH1N1(P0), H9N2:pH1N1(P7) 
and A/Cal/04/09 influenza viruses in pigs. Three pigs were intranasally inoculated with 6,5 log10 TCID50 of 
the indicated virus and housed in three separate isolators. Forty-eight hours later, two direct contact animals 
were co-housed with each inoculated pigs. Each graph is identified with a two digits number: the first one 
corresponds to the isolator number and the second to the virus tested. Therefore, each column represents a 
different virus and each row represents a different isolator. The detection limit (dotted line) of the test was 1.7 
log10 TCID50/100 mg of secretion.
Virus strain
Number of antibody positive pigs (range of antibody titers)
Inoculated pigs (n = 3) Direct contact pigs (n = 6)
0 16 23 29 dpia 0 14 21 28 dpcb
H9N2:pH1N1(P0) 0 (<2) 3 (16–128)
3 (32–
256)
3 (32–
192) 0 (<2)
3 (24–
192)
6 (12–
192)
6 (48–
256)
H9N2:pH1N1(P7) 0 (<2) 3 (48–96)
3 (64–
256)
3 (48–
128) 0 (<2)
5 
(2–256)
4 (96–
256)
4 (64–
192)
A/Cal/04/09 0 (<2) 3 (128–192)
3 (192–
384)
3 (512–
768) 0 (<2)
6 (192–
1024)
6 (256–
1536)
6 (192–
1024)
Table 2. Serum VN antibody titers in inoculated and direct contact pigs involved in transmission experiments 
measured. aDpi: days post-inoculation. bDpc: days post-contact.
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efficiency. We demonstrated, for the first time, that a pig-passaged reassortant H9N2:pH1N1 virus was excreted 
by more than half of the direct-contact pigs at titers similar to those of the parental pH1N1 virus.
Our data confirm the ability of the H9N2:pH1N1 reassortant viruses to infect pigs as was reported in pre-
vious studies17, 18, 28. In fact, virus excretion from the nasal cavity and replication in the respiratory tract were 
present at variable rates during the ten serial pig passages. This finding contrasts with a previous study from our 
Virus stock Segment
Percentage of genes from … 
virus
A/quail/
Hong 
Kong/
G1/1997 
(H9N2)
A/
California/04/2009 
(pH1N1)
H9N2:pH1N1 (P0)
PB2 6 94
PB1 19 81
PA 11 89
HA 100 0
NP 91 9
NA 100 0
M 26 74
NS 91 9
H9N2:pH1N1 (P7)
PB2 0 100
PB1 0 100
PA 0 100
HA 100 0
NP 100 0
NA 100 0
M 0 100
NS 0 100
H9N2:pH1N1 (P7) 
direct-contact
PB2 0 100
PB1 2 98
PA 0 100
HA 100 0
NP 100 0
NA 100 0
M 0 100
NS 0 100
Table 3. Mapping of the reads of the virus stock of H9N2:pH1N1 (P0), H9N2:pH1N1 (P7) and H9N2:pH1N1 
(P7) isolated after direct-contact transmission to the reference genome sample obtained from A/quail/Hong 
Kong/G1/1997 (H9N2) and A/California/04/2009 (pH1N1). The viral gene segment is indicated along with the 
frequency (percentage) of sequence reads originating from either one of the parental strains.
Segment
Nucleotide 
position Reference Mutation Amino acid change
Frequency nasal 
mucosa
Frequency nasal 
swab
PA
1260 T A Trp406Arg — 5.09
1990 TA — Leu649- — 5.56
PB2
220 C G Thr58Ala — 18.55
1651 C T Thr535Met 46.74 —
1891 T C Ile615Thr 8.09 —
HA
407 C T Leu119Phe 27.52 —
750 A G Asp225Gly 47.43 99.70
NS
582 G A NS1:Gly179Gln NS2:Gly22Arg 30.45 —
862 C T NS2: Ala115Val — 25.83
Table 4. Variants present in the passage seven reassortant (H9N2:pH1N1(P7)) virus isolated from the nasal 
mucosa and from the nasal swab of the direct contact pig with the highest excretion. The viral gene segment 
is indicated, along with the nucleotide position and substitutions, the predicted amino acid change and its 
position and the frequency (percentage) of sequence reads with the detected mutations. Only nonsynonymous 
substitutions with a frequency ≥5% in the reads are shown. The virus in the nasal mucosa sample was amplified 
on MDCK cells before sequencing.
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group using the same parental H9N2 virus (A/quail/Hong Kong/G1/1997), however without reassortment with 
pH1N1 internal-protein genes (Mancera Gracia et al.29. In the latter study, replication and shedding of the paren-
tal H9N2 virus was slightly enhanced after four pig passages but it was completely lost after ten passages in pigs. 
This demonstrates that the presence of the well pig-adapted pH1N1-origin internal-protein genes may pose an 
advantage for the adaptation of H9N2 virus to pigs. While the H9N2:pH1N1 (P0) virus did not show replication 
in the lungs during passage one, it replicated homogeneously in the entire respiratory tract during passage two. 
Strikingly, the virus replication in the lungs then progressively decreased during passages four, five and six to 
increase again at passage seven. This suggests the presence of a selection bottleneck due to the genetic pressure 
generated by the experimental set up31. However, a deeper analysis of the viral population would be needed to 
elucidate the possible cause of the decrease in the replication rates.
We consider an influenza virus as swine-adapted when it succeeds to transmit between pigs with a similar 
efficiency as described for the endemic swine influenza viruses. Therefore, we compared pig-to-pig transmission 
of the seventh passage virus with that of the original reassortant and pH1N1 viruses. Whereas both reassortant 
viruses transmitted to direct-contact pigs, the seventh passage virus was clearly shed at higher titers by four out 
of six direct-contact pigs. This virus also showed higher transmission efficiency when compared with previous 
studies describing H9N2:pH1N1 reassortant viruses in pigs17, 28. In the aforementioned studies ≤50% of the 
direct-contact pigs excreted virus. This higher transmission rate suggests that the serial passaging in pigs con-
tributed to the adaptation of the reassortant H9N2 virus. Yet of the six direct-contact pigs two animals that were 
housed in the same isolator did not excrete virus at all. This is most likely due to the low amount of virus excreted 
by the direct-inoculated pig (AUC 17.1), which not have reached a critical threshold to allow virus transmission. 
Further detailed genetic analyses of the virus excreted by the donor pig would be needed to better understand if 
there is, besides the low titer, also a genetic basis for the lack of transmission.
To elucidate the effects of the serial passaging and the pig-to-pig transmission on the virus population, we 
compared the viral diversity in the original reassortant virus with the virus isolated after seven passages in pigs 
and the virus excreted after direct-contact transmission. It should be mentioned here that we detected H9N2 
internal-gene segments in our original reassortant virus stock. Interestingly, the serial passaging resulted 
in the purification of the original virus and, after seven passages only the NP-coding gene was completely of 
H9N2-origin. As in the original stock the H9N2-derive NP gene segment was present at 91%, this high percentage 
might have been the reason for the purification towards the H9N2-origin instead of towards the pH1N1-origin 
as seen for the other gene segments. However, the NS-coding gene showed the same percentage of contamination 
and was completely selected upon passaging. Although previous studies demonstrated that pH1N1-origin inter-
nal genes conferred an advantage in replication and transmission of influenza viruses in mammals27, 32–36, those 
studies focused either on the role of the PB2 and the M-coding genes or on the complete internal gene cassette. 
Not much is known about the exact role of pH1N1-origin NP-protein gene in the adaptation of influenza viruses 
to mammals. However, it has been described that the interaction between the NP and importin-α can influence 
the influenza virus host range. For example, the presence of the NP-N319K substitution was described as an 
important factor for the replication of H7N7 viruses in mice37. Nevertheless, both the H9N2 and the pH1N1 
NP-protein genes lack that mutation. Thus, further analysis with reverse genetic generated reassortants would be 
necessary to elucidate if the combination of H9N2-origin NP-protein gene and pH1N1-origin internal genes has 
an effect in the replication and transmission of influenza viruses in mammals. Regarding the mutations detected 
during the analysis, only one of the mutations that appeared in the virus after seven passages and was main-
tained even after transmission, the HA-D225G substitution in the RBS. This mutation was therefore likely asso-
ciated with the higher replication and transmission efficiency of the H9N2:pH1N1 (P7) virus. Interestingly, this 
mutation was present in all forty-seven swine and seventeen human H9N2 field isolates available in GenBank 
in November 2016. This mutation was also associated with enhanced replication and transmission of paren-
tal H9N2 after four passages in pigs (Mancera Gracia et al., manuscript under review). In the 1918 and 2009 
pandemic H1N1 viruses this mutation has been associated with increased Siaα2,3Gal tropism38, 39. In pigs and 
humans Siaα2,3Gal receptors are mainly found in the lungs13. The presence of the HA-D225G mutation after 
seven passages may therefore explain the consistent replication in the lungs during passage eight. Although spe-
cific receptor-binding tests would be necessary to elucidate the exact role of the HA-D225G mutation within the 
HA-RBS, our data suggest that it may be a marker for adaptation of H9N2 viruses to swine.
In line with previous studies17, 28, this report demonstrated that avian H9N2 influenza viruses can reassort 
with pH1N1 internal genes, resulting in enhanced virus transmission in pigs when compared to the parental, 
non-reassorted H9N2 virus. The present study also underscores that repeated introduction of reassortant H9N2 
viruses into the swine or humans may result in the selection of virus variants with a transmission efficiency close 
to that of the endemic swine or human influenza viruses. However, the lack of transmission detected in one of the 
contact groups used for transmission of passage seven virus, emphasizes the complexity of the adaptation process 
of an avian virus to a mammalian species and the need for additional research to better understand this crucial 
step in cross-species transmission of influenza viruses.
Materials and Methods
Viruses. The reassortant virus containing A/California/04/2009 (pH1N1) internal genes and A/quail/
Hong Kong/G1/1997 (H9N2) HA and NA was produced by reverse genetics at the Department of Diagnostic/
Pathobiology at Kansas State University. The virus was plaque purified, passaged three times in MDCK cells, 
characterized and experimentally validated17. Another passage in MDCK cells was made at the arrival of the virus 
to the Laboratory of Virology at Ghent University to generate a stock to be used in this study.
A/California/04/2009 (pH1N1) was kindly provided by the Centers for Disease Control and Prevention (US 
CDC). The virus underwent three passages in MDCK cells at the US CDC. Later one passage in eggs and one in 
MDCK cells were performed in the Laboratory of Virology at Ghent University before use.
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Pig passages and transmission studies. Forty-seven three-week-old piglets were purchased from a com-
mercial herd free of swine influenza and porcine reproductive and respiratory syndrome virus. Upon arrival, 
pigs were confirmed seronegative to influenza virus with a commercial blocking anti-influenza A nucleocap-
sid ELISA (ID-VET) and by virus neutralization (VN) tests. Consecutive passages started with the housing of 
two pigs in a biosafety level-3 (BSL-3) HEPA filtered isolator, and their intranasal inoculation with three ml of 
phosphate-buffered saline (PBS) containing 106.5 TCID50 of virus. Pigs were clinically monitored daily for gen-
eral (depression, anorexia) and respiratory (coughing, dyspnoea, abdominal thumping, tachypnoea) symptoms. 
Nasal swabs were also collected daily from 0 to four dpi. At four dpi both pigs were euthanized with a lethal dose 
of pentobarbital sodium (≥100 mg/kg) in the jugular vein. The following tissue samples were collected for virus 
titrations: nasal mucosa respiratory part (i.e. nasal turbinates), nasal mucosa olfactory part (i.e. ethmoid laby-
rinth), trachea (distal and proximal half) and five different samples representative of the entire lung. The nasal 
mucosae (respiratory part) were pooled and a 20% (w/v) tissue homogenate was prepared and used to inoculate 
two pigs with this passage one virus inoculum. Ten blind (meaning that the viral load in the inoculum was not 
known prior to the infection) serial passages were performed in this way. Nasal swabs from all pigs, tissue samples 
and the inocula used for the subsequent passages were titrated on MDCK cells.
For each transmission experiment nine three-week-old pigs were used. At 0 dpi three pigs were housed in 
three separate BSL-3 HEPA filtered isolators (one index pig per isolator) and intranasally inoculated with 106.5 
TCID50 of the respective virus. Two dpi, two pigs were introduced in each isolator allowing direct contact with 
the inoculated pig. All animals were clinically monitored and nasal swabs for virus isolation were collected daily 
from all pigs during eleven days after cohousing. Sixteen dpi, the animals were relocated to a BSL-2 HEPA filtered 
isolation unit. Serum samples were collected at 0, 16, 23 and 30 dpi and 0, 14, 21 and 28 days post-contact.
Ethical statement. All experimental procedures were conducted in accordance with the E. U. Animal 
Welfare Directives, and were authorized and supervised by the Local Ethical and Animal Welfare Committee of 
the Faculty of Veterinary Medicine, Ghent University (EC2013/63 number).
Virus titrations. Nasal swabs from both nostrils were suspended in 1 ml PBS supplemented with 10% foetal 
bovine serum, 100 IU/ml penicillin and 100 μg/ml streptomycin and mixed vigorously at 4 °C for 1 hour. Tissue 
samples were weighed and grounded in PBS with 10 IU/ml penicillin and 10 µg/ml streptomycin to obtain 20% 
(w/v) tissue homogenates. Briefly, confluent monolayers of cells were inoculated with 10-fold serial dilutions of 
the sample. After five days of incubation at 37 °C with 5% CO2, virus positive MDCK cells were visualized by 
immunoperoxidase staining. The cells were fixed with 4% paraformaldehyde for ten minutes at room tempera-
ture and subsequently incubated with mouse anti-NP monoclonal HB-65 antibody (1:50, ATCC) for two hours. 
Incubation with horseradish peroxidase-conjugated goat anti-mouse polyclonal antibody (1:200, Dako) for one 
hour was followed by a development step with H2O2 as substrate and 3-amino-9-ethyl-carbazole (AEC) as precip-
itating agent. Virus titers were calculated by the method of Reed and Muench (1938) and expressed as log10 50% 
tissue culture infective doses (TCID50) per 100 milligram (nasal swabs) or per gram (tissues).
Virus neutralization assays. VN tests were performed on MDCK cells in 96-well plates, using 100 TCID50 
of virus per well as previously described40. Briefly, 2-fold serum dilutions were incubated (1 h, 37 °C) with 100 
TCID50 of MDCK cell-grown virus. MDCK cells (800.000 cells per ml) were incubated with the virus-serum 
mixture for 24 h, after which the virus positive cells were visualized by immunoperoxidase staining. Antibody 
titers were expressed as the reciprocal of the highest serum dilution that completely inhibited virus replication in 
MDCK cells.
Data analysis. Nasal virus shedding of individual pigs was quantified by calculation of the AUC. The means 
of the AUCs of different viruses were compared using standard two–sample Mann-Whitney U tests. Differences 
were considered significant when p < 0.05. GraphPad Prism Software, version 5, was used for statistical analyses.
RT-PCR. The RNA from the virus samples was isolated using the QIAamp Viral RNA Mini Kit 
(Qiagen, Valencia, CA). cDNA was synthesized with the Transcriptor First Strand Synthesis kit (Roche), 
already described41. Two separate reactions were performed, using primers specific for the influenza A 
vRNAs: CommonUni12G (GCCGGAGCTCTGCAGATATCAGCGAAAGCAGG) and CommonUni12A 
(GCCGGAGCTCTGCAGATATCAGCAAAAGCAGG). Subsequently, all eight genomic segments were ampli-
fied in one PCR reaction containing an 1:1 mix of CommonUni12G and CommonUni12A cDNA, primer 
CommonUni13 (GCCGGAGCTCTGCAGATATCAGTAGAAACAAGG) (200 nM) and the Phusion High 
Fidelity polymerase (Thermo Scientific)41–43. RT-PCR was performed as described41, with the first 5 PCR cycles 
performed with an annealing temperature of 45 °C (instead of 72 °C). PCR products were purified using the High 
Pure PCR Product Purification Kit (Roche) and elution of the DNA in sterile ultrapure water.
Illumina MiSeq library preparation and sequencing. 500 ng of each purified RT-PCR sample was 
sheared with an M220 focused-ultrasonicator (Covaris) set to obtain peak fragment lengths of 400 bp. Next the 
NEBNext Ultra DNA Library Preparation kit (New England Biolabs) was used to repair the ends and to add 
the Illumina MiSeq-compatible barcode adapters to 100 ng of fragmented DNA. The resulting fragments were 
size-selected at 300 to 400 bp using Agencourt AMPure XP bead sizing (Beckman Coulter). Then, indexes were 
added in a limited-cycle PCR (10 cycles), followed by purification on Agencourt AMpure XP beads. The frag-
ments were analysed on a High Sensitivity DNA Chip on the Bioanalyzer (Agilent Technologies) before loading 
on the sequencing chip. After the 2 × 250 bp MiSeq paired-end sequencing run, the data were base-called and 
converted to Illumina FASTQ files (Phred +64 encoding).
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Next Generation Sequencing data analysis. Sequence data analyses were performed on the resulting 
Illumina FASTQ files (Phred 64+ encoding) using CLC Genomics Workbench (Version 7.0.3) following the anal-
ysis pipeline as described41. The processed sequencing reads were subsequently mapped to the de novo assembled 
consensus sequence of the H9N2:pH1N1 (P7) stock virus sequence. This consensus sequence is available through 
GenBank accession number (KY785904-KY785911). The processed sequencing reads for the H9N2:pH1N1 (P7) 
stock virus were mapped to a reference genome composed of the H9N2:pH1N1 (P7) stock virus sequence and 
the A/quail/Hong Kong/G1/1997(H9N2) virus genome. The raw sequencing data were submitted to the NCBI 
Sequence Read Archive where they can be found under project number: SRP095510.
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